Parental compliance and reasons for COVID-19 Vaccination among American children

PLOS Digit Health. 2023 Apr 12;2(4):e0000147. doi: 10.1371/journal.pdig.0000147. eCollection 2023 Apr.

Abstract

COVID-19 vaccination rates among children have stalled, while new coronavirus strains continue to emerge. To improve child vaccination rates, policymakers must better understand parental preferences and reasons for COVID-19 vaccination among their children. Cross-sectional surveys were administered online to 30,174 US parents with at least one child of COVID-19 vaccine eligible age (5-17 years) between January 1 and May 9, 2022. Participants self-reported willingness to vaccinate their child and reasons for refusal, and answered additional questions about demographics, pandemic related behavior, and vaccination status. Willingness to vaccinate a child for COVID-19 was strongly associated with parental vaccination status (multivariate odds ratio 97.9, 95% confidence interval 86.9-111.0). The majority of fully vaccinated (86%) and unvaccinated (84%) parents reported concordant vaccination preferences for their eligible child. Age and education had differing relationships by vaccination status, with higher age and education positively associated with willingness among vaccinated parents. Among all parents unwilling to vaccinate their children, the two most frequently reported reasons were possible side effects (47%) and that vaccines are too new (44%). Unvaccinated parents were much more likely to list a lack of trust in government (41% to 21%, p < .001) and a lack of trust in scientists (34% to 19%, p < .001) as reasons for refusal. Cluster analysis identified three groups of unwilling parents based on their reasons for refusal to vaccinate, with distinct concerns that may be obscured when analyzed in aggregate. Factors associated with willingness to vaccinate children and reasons for refusal may inform targeted approaches to increase vaccination.

Grants and funding

This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (K23 DK120899 to CMA) and the Centers for Disease Control and Prevention (Contract Number 75D30121C11606 to BR, AG and JB). BR, AG & JB were funded on the same contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.